Euclidean Capital LLC - Stock Holdings in 13F Filings (SEC)

Updated on March 15, 2026.

Based on 13F Filings filed with the SEC on February 17, 2026, for the 2025 Q4 period, Euclidean Capital LLC held in its portfolio 12 assets valued at $369,450,641 (i.e. $369.45M).

The most valuable assets in the portfolio included: VANGUARD INTL EQUITY INDEX F ($219.95M), VANGUARD INDEX FDS ($99.32M), and ISHARES TR ($19.98M).

The chart below shows the top 10 valuable assets, and the table below shows the top 12 valuable assets.

You can see similar for other investment managers.

Related Topics: SEC Topic List.

Data Source: SEC.

Top Valuable Stocks in Euclidean Capital LLC Portfolio

VANGUARD INTL EQUITY INDEX F

VANGUARD INDEX FDS

ISHARES TR

FOGHORN THERAPEUTICS INC

ORIC PHARMACEUTICALS INC

PMV PHARMACEUTICALS INC

SPDR S&P 500 ETF TR

RAPT THERAPEUTICS INC

ALECTOR INC

SURROZEN INC

Euclidean Capital LLC - Stock Holdings in 13F Filings (SEC)

Items per page:

0 of 0

Name of Issuer	No. of Shares	Value ($)	Class
VANGUARD INTL EQUITY INDEX F	2990084	219950579	ALLWRLD EX US
VANGUARD INDEX FDS	520000	99314800	VALUE ETF
ISHARES TR	369600	19976880	MSCI INDIA ETF
FOGHORN THERAPEUTICS INC	1573761	8498309	COM
ORIC PHARMACEUTICALS INC	989410	8093374	COM
PMV PHARMACEUTICALS INC	2627643	3284554	COM
SPDR S&P 500 ETF TR	4104	2798600	TR UNIT
RAPT THERAPEUTICS INC	82234	2785266	COM NEW
ALECTOR INC	1307858	2040258	COM
SURROZEN INC	87696	1981930	COM NEW
TENAYA THERAPEUTICS INC	1015705	722674	COM
SURROZEN INC	170833	3417	*W EXP 08/01/203